Shiqiu Qiu
Overview
Explore the profile of Shiqiu Qiu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou L, Guan Z, Chen C, Zhu Q, Qiu S, Liu Y, et al.
Front Cell Infect Microbiol
. 2023 Jan;
12:1072463.
PMID: 36699718
Introduction: () Microsporidia can cause opportunistic infections in immunocompromised patients and is also an emerging disease in these individuals. Its clinical manifestations are chronic diarrhea and severe wasting syndrome, these...
2.
Sun X, Zhou X, Zhuang J, Qiu S, Liu Z, Li Q, et al.
Haemophilia
. 2022 Nov;
29(1):362-364.
PMID: 36418153
No abstract available.
3.
Zhu Q, Li H, Zheng S, Wang B, Li M, Zeng W, et al.
Front Immunol
. 2022 Apr;
13:856039.
PMID: 35432366
To investigate the Th1/Th2 cytokine profile in patients with lymphoma during the myelosuppression stage of infection. 52 patients with gram-negative bacterial infection (G- group), 49 patients with gram-positive bacterial infection...
4.
Xiao D, Li W, Zhang W, Wen Z, Dai B, Mo W, et al.
Nutr Cancer
. 2021 Sep;
74(6):1958-1967.
PMID: 34553663
Studies have shown that the micronutrients, zinc (Zn), copper (Cu), and selenium (Se) are associated with the HPV-associated cervical cancer, yet between dietary Zn/Cu/Se intake and high-risk HPV (hrHPV) infection...
5.
Zhu Q, Yang S, Zeng W, Li M, Guan Z, Zhou L, et al.
Front Oncol
. 2021 Sep;
11:701539.
PMID: 34490101
This real-world, observational study aimed to assess and compare the clinical efficacy and safety of eltrombopag with recombinant human thrombopoietin (rhTPO) in the treatment of chemotherapy induced thrombocytopenia (CIT) in...
6.
Zhou L, Liu Y, Wen Z, Yang S, Li M, Zhu Q, et al.
J Cancer Res Clin Oncol
. 2020 Jul;
146(11):3063-3074.
PMID: 32617699
Purpose: Case reports suggest that ruxolitinib-containing treatment could increase the clinical response rate of patients with hemophagocytic syndrome (HPS). This study aimed to explore the effect of ruxolitinib-containing treatment for...